Brilliance in India: New Deal Allows Bay Area Firm to Fight Jaundice

The Bay Area-based non-profit technology design firm D-Rev has inked its largest distribution deal since launching in 2007.

D-Rev—co-founded by Paul Polak—announced today that Phoenix Medical Systems in India will run the marketing and distribution of D-Rev’s Brilliance product, a neo-natal phototherapy device used to treat infants with the brain-damaging disease, jaundice, and which comes at a price tag of $400 instead of the usual $3,000.

Read More